首页> 外文期刊>海南医科大学学报(英文版) >Effects of telmisartan combined with nifedipine controlled release tablet on inflammatory factors, vascular endothelial function and left ventricular function in patients with coronary heart disease with mild to moderate hypertension
【24h】

Effects of telmisartan combined with nifedipine controlled release tablet on inflammatory factors, vascular endothelial function and left ventricular function in patients with coronary heart disease with mild to moderate hypertension

机译:替米沙坦联合硝苯地平控释片对轻度至中度高血压冠心病患者炎症因子,血管内皮功能和左心室功能的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To investigate the effect of telmisartan combined with Nifedipine Controlled Release Tablet on inflammatory factors, vascular endothelial function and left ventricular function in patients with coronary heart disease with mild to moderate hypertension. Methods:A total of 92 cases of patients with coronary heart disease with mild to moderate hypertension were selected as the object of observation, according to the random data table, they were divided into the control group (n=46) and observation group (n=46), and patients in the control group were treated with Nifedipine Controlled Release Table therapy, on this basis, the observation group patients were given telmisartan treatment, two groups were treated for 6 months. The levels of the blood pressure, inflammatory factors, vascular endothelial function and left ventricular function compared between the two groups before and after treatment. Results: There were no significant differences in the levels of SBP, DBP, hs-CRP, TNF-α, NO, ET-1, LVEF, LVEDD and LVESD in the two groups before treatment. After treatment, two groups of SBP, DBP, hs-CRP, TNF-α, ET-1, LVEDD and LVESD levels were significantly lower than those in the same group before treatment, and after treatment, the levels of SBP, DBP, hs-CRP, TNF-α, ET-1 and LVESD in the observation group were significantly lower than those in the control group, while there were no significant difference in the level of LVEDD between the two groups after treatment;Compared with level in the group before treatment, the levels of NO and LVEF in the two groups were significantly increased, and the observation group [(82.13±19.01) μmol/L, (52.83±7.45)%] was significantly higher than the control group ((67.37±13.08) μmol/L, (49.47±6.96)%)Conclusion: Telmisartan combined with Nifedipine Controlled Release Table in treating coronary heart disease with mild to moderate hypertension, can effectively control blood pressure, reduce the inflammatory stress, improve vascular endothelial function and left ventricular function of patients, has an important clinical value.
机译:目的:探讨替米沙坦联合硝苯地平控释片对轻度至中度高血压冠心病患者炎症因子,血管内皮功能和左心室功能的影响。方法:选择92例轻度至中度高血压冠心病患者作为观察对象,根据随机数据表将其分为对照组(n = 46)和观察组(n = 46)。 = 46),对照组患者接受硝苯地平控释表治疗,在此基础上,观察组患者给予替米沙坦治疗,两组均治疗6个月。比较两组治疗前后的血压,炎症因子,血管内皮功能和左心室功能水平。结果:治疗前两组患者的SBP,DBP,hs-CRP,TNF-α,NO,ET-1,LVEF,LVEDD和LVESD水平无显着差异。治疗后,两组SBP,DBP,hs-CRP,TNF-α,ET-1,LVEDD和LVESD水平明显低于同一组,治疗前,治疗后SBP,DBP,hs水平观察组患者的-CRP,TNF-α,ET-1和LVESD均显着低于对照组,而治疗后两组的LVEDD水平无明显差异;与对照组比较治疗前两组NO和LVEF水平明显升高,观察组[(82.13±19.01)μmol/ L,(52.83±7.45)%]明显高于对照组((67.37±13.08)。 )μmol/ L,(49.47±6.96)%)结论:替米沙坦联合硝苯地平控释表治疗轻度至中度高血压的冠心病,可以有效控制血压,减轻炎症应激,改善血管内皮功能和左心室患者的功能,有一个IM重要的临床价值。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号